Allos Therapeutics' Folotyn meets goal in midstage lung cancer study: Allos Therapeutics Inc. said Wednesday its d... http://bit.ly/dib85k
10:22 AM - 28 Jul 2010
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.